Assignee
RAADYSAN BIOTECH INC
US·3 granted patents·1 pending application·2 citations·filing 2015–2023
Top patents by PatentIndex Score
4 records- 0176US9546366B2Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancerRAADYSAN BIOTECH INC·Filed 2015·Granted Jan 17, 2017·2 cites·14 claims
- 0257US2025162990A1Compounds and methods for inhibiting cancers over-expressing replication factor c 40RAADYSAN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0355US9822363B2Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancerRAADYSAN BIOTECH INC·Filed 2017·Granted Nov 21, 2017·0 cites·7 claims
- 0452US9970012B2Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancerRAADYSAN BIOTECH INC·Filed 2017·Granted May 15, 2018·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when RAADYSAN BIOTECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →